AKT1 and nasopharyngeal carcinoma: Guo et al. observed that BT exerts anticancer effects in nasopharyngeal carcinoma via suppression of the AKT/mTOR signaling pathway and inhibits cell proliferation by inhibiting the PI3K/AKT/mTOR pathway [8, 19].